Plasmodium vivax Drug Resistance Genes; Pvmdr1 and Pvcrt-o Polymorphisms in Relation to Chloroquine Sensitivity from a Malaria Endemic Area of Thailand
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The aim of the study was to explore the possible molecular markers of chloroquine resistance in Plasmodium vivax isolates in Thailand. A total of 30 P. vivax isolates were collected from a malaria endemic area along the Thai-Myanmar border in Mae Sot district of Thailand. Dried blood spot samples were collected for analysis of Pvmdr1 and Pvcrt-o polymorphisms. Blood samples (100 μl) were collected by finger-prick for in vitro chloroquine susceptibility testing by schizont maturation inhibition assay. Based on the cut-off IC50 of 100 nM, 19 (63.3%) isolates were classified as chloroquine resistant P. vivax isolates. Seven non-synonymous mutations and 2 synonymous were identified in Pvmdr1 gene. Y976F and F1076L mutations were detected in 7 (23.3%) and 16 isolates (53.3%), respectively. Analysis of Pvcrt-o gene revealed that all isolates were wild-type. Our results suggest that chloroquine resistance gene is now spreading in this area. Monitoring of chloroquine resistant molecular markers provide a useful tool for future control of P. vivax malaria.
Abstract
The aim of the study was to explore the possible molecular markers of chloroquine resistance in Plasmodium vivax isolates in Thailand. A total of 30 P. vivax isolates were collected from a malaria endemic area along the Thai-Myanmar border in Mae Sot district of Thailand. Dried blood spot samples were collected for analysis of Pvmdr1 and Pvcrt-o polymorphisms. Blood samples (100 μl) were collected by finger-prick for in vitro chloroquine susceptibility testing by schizont maturation inhibition assay. Based on the cut-off IC50 of 100 nM, 19 (63.3%) isolates were classified as chloroquine resistant P. vivax isolates. Seven non-synonymous mutations and 2 synonymous were identified in Pvmdr1 gene. Y976F and F1076L mutations were detected in 7 (23.3%) and 16 isolates (53.3%), respectively. Analysis of Pvcrt-o gene revealed that all isolates were wild-type. Our results suggest that chloroquine resistance gene is now spreading in this area. Monitoring of chloroquine resistant molecular markers provide a useful tool for future control of P. vivax malaria.
참고문헌 (22)
- The use of antimalarial drugs. Report of a WHO informal consultation, "World Health Organization", World Health Organization, ~, pp.Report WHO (2001), CDS[DOI]
- Rieckmann KH, "Plasmodium vivax resistance to chloroquine?", Lancet, 2, pp.1183~1184 (1989)
- Baird JK, "Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia", Am J Trop Med Hyg, 44, pp.547~552 (1991)
- Marlar-Than, "Development of resistance to chloroquine by Plasmodium vivax in Myanmar", Trans R Soc Trop Med Hyg, 89, pp.307~308 (1995)
- Baird JK, "Survey of resistance to chloroquine by Plasmodium vivax in Indonesia", Trans R Soc Trop Med Hyg, 90, pp.409~411 (1996)
- Dua VK, "Chloroquine resistant Plasmodium vivax malaria in India", Trop Med Int Health, 1, pp.816~819 (1996)
- Phan GT, "Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam", Trop Med Int Health, 7, pp.858~864 (2002)
- Lee KS, "Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea", Am J Trop Med Hyg, 80, pp.215~217 (2009)
- Chotivanich K, "In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand", Am J Trop Med Hyg, 70, pp.395~397 (2004)
- Suwanarusk R, "Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms", PLoS One, 2, pp.e1089~ (2007)
- Brega S, "Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity", J Infect Dis, 191, pp.272~277 (2005)
- Lu F, "Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries", Acta Trop, 117, pp.69~75 (2011)
- Orjuela-Sánchez P, "Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region", Antimicrob Agents Chemother, 53, pp.3561~3564 (2009)
- Sá JM, "Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains", Exp Parasitol, 109, pp.256~259 (2005)
- Barnadas C, "Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes", Antimicrob Agents Chemother, 52, pp.4233~4240 (2008)
- Wongsrichanalai C, "Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders", Southeast Asian J Trop Med Public Health, 32, pp.41~49 (2001)
- Wongsrichanalai C, "Epidemiology of drug-resistant malaria", Lancet Infect Dis, 2, pp.209~218 (2002)
- Russell BM, "Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic", Antimicrob Agents Chemother, 47, pp.170~173 (2003)
- Congpuong K, "Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province, Thailand", Acta Trop, 83, pp.117~121 (2002)
- Rijken MJ, "Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand", Malar J, 10, pp.113~ (2011)
- Fidock DA, "Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance", Mol Cell, 6, pp.861~871 (2000)
- Nomura T, "Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria", J Infect Dis, 183, pp.1653~1661 (2001)